Brian P. McKeon - 31 May 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2024, 16:58:59 UTC
Prior SEC filing
20 Feb 2024
Next SEC filing
01 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shantale Greenson, attorney-in-fact for Brian P. McKeon

Key filing fact

Brian P. McKeon filed Form 4 for Alkermes plc. (ALKS) on 04 Jun 2024.

Key facts

  • This page summarizes Brian P. McKeon's Form 4 filing for Alkermes plc. (ALKS).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2024, 16:58.

Change

  • Previous filing in this sequence was filed on 20 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALKS transaction Derivative

Restricted Stock Unit Award

Award

Transaction value
$0
Shares
+8,013
Change %
Price
$0.000000
Shares after
8,013
Date
31 May 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
8,013
Exercise price
Footnotes
F1, F2
ALKS transaction Derivative

Non Qualified Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+17,492
Change %
Price
$0.000000
Shares after
17,492
Date
31 May 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
17,492
Exercise price
$23.40
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one ordinary share.

Footnote F2

Shares subject to the restricted stock unit award vest in full on 5/31/2025.

Footnote F3

Shares subject to the stock option award vest and become exercisable in full on 5/31/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .